Literature DB >> 9951473

New surgical approach for removing massive foveal hard exudates in diabetic macular edema.

H Takagi1, A Otani, J Kiryu, Y Ogura.   

Abstract

OBJECTIVE: To examine the efficacy of surgical removal of foveal hard exudates in diabetic macular edema and to determine the expression of vascular endothelial growth factor (VEGF) in the excised specimens.
DESIGN: Cohort study. PARTICIPANTS: Seven eyes of six patients with massive subfoveal hard exudate due to diabetic macular edema were examined. The average age of the patient was 56 years (range, 46-60 years). INTERVENTION: Pars plana vitrectomy for removal of massive foveal exudates was performed. MAIN OUTCOME MEASURES: Preoperative and postoperative visual acuity and complications were recorded; immunohistochemical staining for VEGF and other cell markers for macrophage and pigment epithelial cells in excised specimens was performed.
RESULTS: Postoperative best-corrected visual acuity improved by two or more lines of Snellen equivalent in five eyes (71%) (P = 0.0061). VEGF, identified by anticytokeratin and CD68 antibodies, was expressed in pigment epithelial cells and macrophages invading the hard exudates.
CONCLUSION: Surgical removal of foveal hard exudates might be effective in low-vision patients with diabetic maculopathy. VEGF might play a role in the formation and persistence of foveal hard exudates in diabetic macular edema.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9951473     DOI: 10.1016/S0161-6420(99)90054-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  18 in total

1.  Using multifocal electroretinography hard exudates affect macular function in eyes with diabetic retinopathy.

Authors:  Kristina Holm; Vesna Ponjavic; Monica Lövestam-Adrian
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-30       Impact factor: 3.117

2.  Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.

Authors:  Julia A Haller; Haijing Qin; Rajendra S Apte; Roy R Beck; Neil M Bressler; David J Browning; Ronald P Danis; Adam R Glassman; Joseph M Googe; Craig Kollman; Andreas K Lauer; Mark A Peters; Margaret E Stockman
Journal:  Ophthalmology       Date:  2010-03-17       Impact factor: 12.079

3.  Triamcinolone acetonide suppresses interleukin-1 beta-mediated increase in vascular endothelial growth factor expression in cultured rat Müller cells.

Authors:  Hirotaka Itakura; Hideo Akiyama; Norikazu Hagimura; Hiroshi Doi; Toru Tanaka; Shoji Kishi; Masahiko Kurabayashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-28       Impact factor: 3.117

4.  Choroidal neovascularisation after surgical removal of submacular lipid plaques in diabetic maculopathy.

Authors:  Daniela Suesskind; Faik Gelisken; Karl U Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-09-19       Impact factor: 3.117

5.  Comparison of the efficacy between an intravitreal and a posterior subtenon injection of triamcinolone acetonide for the treatment of diffuse diabetic macular edema.

Authors:  Rao Muhammad Rashad Qamar; Muhammad Imran Saleem; Muhammad Farhan Saleem
Journal:  Eurasian J Med       Date:  2013-10

6.  Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.

Authors:  Remzi Avci; Berkant Kaderli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-21       Impact factor: 3.117

7.  Planned foveal detachment technique for the resolution of diffuse diabetic macular edema.

Authors:  Yuki Morizane; Shuhei Kimura; Mio Hosokawa; Yusuke Shiode; Masayuki Hirano; Shinichiro Doi; Mika Hosogi; Atsushi Fujiwara; Yasushi Inoue; Fumio Shiraga
Journal:  Jpn J Ophthalmol       Date:  2015-07-30       Impact factor: 2.447

8.  OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS OF MACULAR EDEMA AND HARD EXUDATES AND THEIR ASSOCIATION WITH LIPID SERUM LEVELS IN TYPE 2 DIABETES.

Authors:  Samaneh Davoudi; Evangelia Papavasileiou; Ramak Roohipoor; Heeyoon Cho; Shreyas Kudrimoti; Heather Hancock; Suzanne Hoadley; Christopher Andreoli; Deeba Husain; Maurice James; Alan Penman; Ching J Chen; Lucia Sobrin
Journal:  Retina       Date:  2016-09       Impact factor: 4.256

Review 9.  Diabetic macular edema: New promising therapies.

Authors:  Hanan N Al Shamsi; Jluwi S Masaud; Nicola G Ghazi
Journal:  World J Diabetes       Date:  2013-12-15

Review 10.  Diabetic retinopathy: an update.

Authors:  Ramandeep Singh; Kim Ramasamy; Chandran Abraham; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.